These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 5942129)
1. [Activity of mouse cerebral monoamine oxidase as a function of the means of administration of a MAO inhibitor]. Levy J; Michel-Ber E Therapie; 1966; 21(3):633-44. PubMed ID: 5942129 [No Abstract] [Full Text] [Related]
2. Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium. Jo YS; Huong DT; Bae K; Lee MK; Kim YH Planta Med; 2002 Jan; 68(1):84-5. PubMed ID: 11842339 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674 [TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke. Khalil AA; Davies B; Castagnoli N Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520 [TBL] [Abstract][Full Text] [Related]
5. [Effect of D,L-malic acid dibenzylhydrazide on changes in the antioxidizing activity of lipids and monoamine oxidase activity in mouse organs]. Kairane ChB; Baumanis EA; Burlakova EB; Gorkin VZ; Kalninia IE Vopr Med Khim; 1979; 25(6):776-81. PubMed ID: 516540 [TBL] [Abstract][Full Text] [Related]
6. Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitor. White HL; Ascher JA Clin Neuropharmacol; 1993; 16 Suppl 2():S25-33. PubMed ID: 8313394 [TBL] [Abstract][Full Text] [Related]
7. [Effect of various antidepressive agents on brain monoamine oxidase activity]. Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732 [TBL] [Abstract][Full Text] [Related]
8. FA-70, a novel selective and irreversible monoamine oxidase-A inhibitor: effect on monoamine metabolism in mouse cerebral cortex. Morón JA; Pérez V; Pastó M; Lizcano JM; Unzeta M J Pharmacol Exp Ther; 2000 Feb; 292(2):788-94. PubMed ID: 10640319 [TBL] [Abstract][Full Text] [Related]
9. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay. Guang HM; Du GH Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097 [TBL] [Abstract][Full Text] [Related]
10. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A. Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357 [TBL] [Abstract][Full Text] [Related]
11. The nature of inhibition of thyroid monoamine oxidase by thyroxine in rat thyroid. Knopp J Endokrinologie; 1982 Nov; 80(3):367-70. PubMed ID: 7166166 [TBL] [Abstract][Full Text] [Related]
12. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Youdim MB; Fridkin M; Zheng H Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Youdim MB; Weinstock M Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899 [TBL] [Abstract][Full Text] [Related]
14. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity]. Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204 [TBL] [Abstract][Full Text] [Related]
15. Increase of monoamine oxidase-B activity in the brain of scrapie-infected hamsters. Adjou KT; Dilda P; Aumond P; Gueddari S; Deslys JP; Dormont D; Seman M Neurochem Int; 2008 Jun; 52(8):1416-21. PubMed ID: 18442871 [TBL] [Abstract][Full Text] [Related]
16. Methylpiperate derivatives from Piper longum and their inhibition of monoamine oxidase. Lee SA; Hwang JS; Han XH; Lee C; Lee MH; Choe SG; Hong SS; Lee D; Lee MK; Hwang BY Arch Pharm Res; 2008 Jun; 31(6):679-83. PubMed ID: 18563347 [TBL] [Abstract][Full Text] [Related]
17. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A. Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925 [TBL] [Abstract][Full Text] [Related]
18. Improvement of mouse brain mitochondrial function after deprenyl treatment. Czerniczyniec A; Bustamante J; Lores-Arnaiz S Neuroscience; 2007 Jan; 144(2):685-93. PubMed ID: 17084986 [TBL] [Abstract][Full Text] [Related]
19. Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery. Lang W; Masucci JA; Caldwell GW; Hageman W; Hall J; Jones WJ; Rafferty BM Anal Biochem; 2004 Oct; 333(1):79-87. PubMed ID: 15351283 [TBL] [Abstract][Full Text] [Related]
20. Effect of chlorpromazine, imipramine and lithium on MAO-A and MAO-B activity in rat brain mitochondria. Nag M Indian J Exp Biol; 2004 Sep; 42(9):941-4. PubMed ID: 15462192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]